Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium [NA]

View source ↗

Summary

A clinical trial evaluating dose-response profiles of uterotonics after initial carbetocin administration in desensitized human myometrium, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)

Snippet

Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Conditions: Postpartum Hemorrhage | NA | Status: RECRUITING